Radient Technologies Inc. Announces Changes to its Board of Directors - Seite 2

Mr. Gougoux is also on the Board of Directors of the Mira Foundation, a non-profit organization that trains and supplies service dogs to blind and handicapped persons as well as children with autism. He completed his business studies at Concordia University in Montréal.  

Resignation of two Board Members:

Radient announces today the resignation of Mr. Steve Dauphin from the Company’s Board of Directors, for personal reasons. Francesco Ferlaino, Radient’s Chairman of the Board, commented, “I would like to thank Steve on behalf of Radient for his significant contributions during his six-year tenure on the Board. His guidance, ongoing support and commitment to the development of the Company will be greatly missed.”

Mr. Dimitris Tzanis will also today be resigning from Radient’s Board of Directors, in order to pursue other interests. “Mr. Tzanis has been a Director of Radient since 2016, and has been a strong supporter of the Company during that time. On behalf of Radient I would like to thank him for his contributions to the Company’s success, and wish him well in his future endeavours,” said Mr. Ferlaino.

About Radient 
Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.

SOURCE: Radient Technologies Inc.

Contact: Caitlin Cheadle, Director of Communications: [e-mail]

Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the impact of changes to the Company’s board of directors; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.